This study sought to assess differences in plasma levels of the adipokines CTRP5 and chemerin between individuals with CAD, characterized by mixed, calcific, or soft plaques across different stages of CCTA-confirmed atherosclerosis, and those without CAD, confirmed by CCTA. This evidence concerns the gene C1QTNF5 and atherosclerosis.